NRG Oncology and its partners have more than 150 years experience in conducting practice-defining, multi-institutional Phase II and III trials sponsored primarily by the National Cancer Institute (NCI), as well as a history of undertaking the kind of Phase I trials and translational biological studies that will be imperative for future clinical can
07-15 February 2022